GlassScriptPhysician profile
William L White
NPI 1497778641
$1,850.39
in general payments reported to CMS, 2019-2025
14 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $62.75 · 2021: $301 · 2022: $366 · 2023: $209 · 2024: $410 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $568.66 | 2021-2023 | Tepezza |
| Amgen INC. | $494.31 | 2024-2025 | Tepezza |
| Mallinckrodt Enterprises LLC | $123.31 | 2019 | |
| Mallinckrodt Hospital Products INC. | $120.55 | 2024-2025 | Acthar |
| Eyepoint US, INC. | $116.23 | 2021 | |
| Dompe US, INC. | $93.87 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $74.98 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $62.73 | 2020-2023 | Cequa |
| Alcon Vision LLC | $53.63 | 2023-2025 | Centurion |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Bausch & Lomb Americas INC. | $38.09 | 2023-2024 | Vyzulta, Miebo |
| Abbvie INC. | $25.17 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $24.34 | 2024 | Xdemvy |
| Allergan, INC. | $15.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.